Moriroku Holdings Company, Ltd. operates as a holding company. The Company, through its subsidiaries, conducts group companies management, corporate indirect operations, and other services. Moriroku Holdings also imports and exports medical products, chemicals, and other products.

[Delayed] Summary Of Consolidated Financial Results For The Six Months Ended September 30, 2024 (Based On Japanese Gaap)

[Delayed] Summary Of Consolidated Financial Results For The Three Months Ended June 30, 2024 (Based On Japanese Gaap)

[Delayed] Corporate Governance Report

[Delayed] Summary Of Consolidated Financial Results For The Year Ended March 31, 2024 (Based On Japanese Gaap)

2022年３月期　第２四半期決算説明会資料

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

[Delayed] Summary Of Consolidated Financial Results For The Six Months Ended September 30, 2024 (Based On Japanese Gaap)

[Delayed] Summary Of Consolidated Financial Results For The Three Months Ended June 30, 2024 (Based On Japanese Gaap)

[Delayed] Corporate Governance Report

[Delayed] Summary Of Consolidated Financial Results For The Year Ended March 31, 2024 (Based On Japanese Gaap)

2022年３月期 第２四半期決算説明会資料

2022年３月期　第２四半期決算説明会資料